CEC Capital advises Zhongkexinyang on 100-million-yuan private financing roundPUBT·1 day ago, 07:09 PM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-RezLondon Stock Exchange·Jul 28 at 05:06 AMGSK-0.73%03692-0.49%
C&Y Pharmaceutical: Net profit in the third quarter was 21.9466 million yuan, a year-on-year increase of 106.06%Zhitong·Oct 29, 2025 at 05:38 AM300254+3.85%
C&Y Pharmaceutical shareholder Weng Zhanguo plans to reduce his holdings by no more than 3%Zhitong·Oct 22, 2025 at 08:17 AM300254+3.85%
C&Y Pharmaceutical: Launching a financing lease sale-leaseback business not exceeding 50 million yuanZhitong·Sep 15, 2025 at 09:50 AM300254+3.85%
The hepatitis concept sector has seen a short-term surgeZhitong·Jul 27, 2025 at 08:36 PM300086+2.78%002022+0.79%
C&Y Pharmaceutical plans to launch a restricted stock incentive plan of no more than 9.15 million sharesZhitong·Jul 22, 2025 at 07:04 AM300254+3.85%
The innovative drug concept has repeatedly strengthened, and Qianhong Bio-pharma has surged to the limit36Kr·Jul 9, 2025 at 09:16 PM688799+3.19%603716+3.38%
C&Y Pharmaceutical: Ebastine raw material drug approved for market launchZhitong·Jul 8, 2025 at 04:23 AM300254+3.85%
The chemical pharmaceutical sector has seen a short-term surge, with ApicHope rising over 10%Zhitong·May 19, 2025 at 08:32 PM300254+3.85%300723+4.13%
C&Y Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 10.3904 million yuan, a decrease of 43.17%Zhitong·Apr 18, 2025 at 08:16 AM300254+3.85%
C&Y Pharmaceutical released its 2024 annual performance, with a net profit attributable to the parent company of 42.1901 million yuan, an increase of 67.45%Zhitong·Apr 14, 2025 at 08:48 AM300254+3.85%
C&Y Pharmaceutical: The impact of U.S. tariff policies on the company is relatively smallZhitong·Apr 8, 2025 at 08:03 PM300254+3.85%
C&Y Pharmaceutical issued a preliminary profit increase announcement, expecting an annual net profit of 40 million to 52 million yuan, a year-on-year increase of 58.76%-106.39%Zhitong·Jan 24, 2025 at 06:43 AM300254+3.85%
C&Y Pharmaceutical's subsidiary has received the clinical trial approval notice for maltol iron capsulesZhitong·Dec 24, 2024 at 04:16 AM300254+3.85%
